Похоже, при загрузке страницы произошла ошибка.
Наша команда получила уведомление. Если проблема сохранится, свяжитесь с нами через виджет поддерж. по email.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | No | Yes |
| Is net profit margin increasing? | Yes | Yes |
| Is asset turnover increasing? | No | Yes |
| Is equity multiplier increasing? | No | No |
| Competitors Used |
|---|
| Acotec Scientific Holdings Limited |
| MicroPort NeuroScientific Corporation |
| Blue Sail Medical Co.,Ltd. |
| Innovita Biological Technology Co., Ltd. |
| Shenzhen YHLO Biotech Co., Ltd. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| 6,669 | 2,172 | 2,382 | 688,253 | 688,575 | 2,190 | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 2% | 14% | -5% | 13% | 12% | 1% | ||
| Fiscal Year - 1 | 6% | -3% | -4% | 10% | 14% | -4% | ||
| Fiscal Year - 2 | -17% | 24% | 11% | 12% | 51% | -11% | ||
| Fiscal Year - 3 | 36% | 17% | 19% | 17% | 18% | -34% | ||
| Fiscal Year - 4 | 62% | 28% | 6% | 146% | 31% | -40% | ||
| Fiscal Year - 5 | NA | NA | 8% | 24% | 24% | NA | ||
| Average | 18% | 16% | 6% | 37% | 25% | -18% | ||
| Median | 6% | 17% | 7% | 15% | 21% | -11% | ||
| Benchmarks | Ticker | |||||||
| Acotec Scientific Holdings Limited | SEHK:6669 | |||||||
| MicroPort NeuroScientific Corporation | SEHK:2172 | |||||||
| Blue Sail Medical Co.,Ltd. | SZSE:002382 | |||||||
| Innovita Biological Technology Co., Ltd. | SHSE:688253 | |||||||
| Shenzhen YHLO Biotech Co., Ltd. | SHSE:688575 | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | Apr-18 | Dec-05 | Jul-06 | May-84 | Apr-85 | Dec-05 | ||
| Latest Fiscal Year | Dec-23 | Dec-23 | Dec-23 | Dec-24 | Dec-24 | Dec-23 | ||
| LTM Period | Jun-24 | Jun-24 | Sep-24 | Dec-24 | Dec-24 | Jun-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 523 | 775 | 5,997 | 621 | 1,992 | 664 | ||
| Fiscal Year | 474 | 666 | 4,927 | 621 | 1,992 | 528 | ||
| Fiscal Year - 1 | 396 | 547 | 4,900 | 478 | 2,053 | 334 | ||
| Fiscal Year - 2 | 304 | 383 | 8,109 | 447 | 3,981 | 178 | ||
| Fiscal Year - 3 | 194 | 222 | 7,869 | 327 | 1,178 | 28 | ||
| Fiscal Year - 4 | 125 | 184 | 3,476 | 1,037 | 999 | 5 | ||
| Fiscal Year - 5 | NA | NA | 2,653 | 138 | 877 | NA | ||
| Net Income | ||||||||
| Latest Twelve Months | 32 | 225 | (433) | 246 | 302 | 26 | ||
| Fiscal Year | 14 | 146 | (568) | 246 | 302 | (79) | ||
| Fiscal Year - 1 | 70 | (22) | (372) | 174 | 355 | (114) | ||
| Fiscal Year - 2 | (79) | 24 | 1,156 | 151 | 1,012 | (200) | ||
| Fiscal Year - 3 | (44) | 45 | 1,758 | 120 | 205 | (100) | ||
| Fiscal Year - 4 | 23 | 47 | 490 | 571 | 211 | (67) | ||
| Fiscal Year - 5 | NA | NA | 347 | 21 | 108 | NA | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 1,605 | 1,893 | 15,346 | 2,066 | 3,806 | 3,297 | ||
| Latest Fiscal Quarter | 1,709 | 2,080 | 16,980 | NA | NA | 3,486 | ||
| Fiscal Year | 1,611 | 1,961 | 15,633 | NA | NA | 3,376 | ||
| Fiscal Year - 1 | 1,411 | 1,817 | 15,873 | 2,066 | 3,806 | 3,254 | ||
| Fiscal Year - 2 | 1,307 | 1,340 | 16,914 | 1,943 | 4,214 | 3,248 | ||
| Fiscal Year - 3 | 273 | 786 | 17,035 | 798 | 2,138 | 504 | ||
| Fiscal Year - 4 | 112 | 335 | 13,259 | 780 | 1,324 | 207 | ||
| Fiscal Year - 5 | NA | NA | 12,698 | 160 | 1,076 | NA | ||
| Fiscal Year - 6 | NA | NA | 1,837 | 98 | 838 | NA | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 1,305 | 1,565 | 9,934 | 1,842 | 2,560 | 3,089 | ||
| Latest Fiscal Quarter | 1,337 | 1,709 | 8,836 | 2,044 | 2,652 | 3,110 | ||
| Fiscal Year | 1,297 | 1,636 | 9,548 | 2,044 | 2,652 | 3,047 | ||
| Fiscal Year - 1 | 1,276 | 1,473 | 10,552 | 1,842 | 2,560 | 3,094 | ||
| Fiscal Year - 2 | 1,207 | (175) | 10,536 | 1,689 | 2,417 | 3,145 | ||
| Fiscal Year - 3 | (281) | 373 | 9,817 | 738 | 1,526 | 425 | ||
| Fiscal Year - 4 | 37 | 168 | 8,432 | 668 | 768 | 166 | ||
| Fiscal Year - 5 | NA | NA | 7,798 | 114 | 579 | NA | ||
| Fiscal Year - 6 | NA | NA | 1,426 | 61 | 333 | NA | ||